- Global Pharma News & Resources

Cell Culture Media Market is expected to reach US$ 25.09 Billion in 2032

The Cell Culture Media Market was worth US$4.9Bn in 2022 and is expected to advance at a CAGR of 16% from 2022 to 2032 to US$25.9 Bn by 2032.

Due to increased research and development investment by private and public businesses for vaccines and treatments against microorganisms, the demand for cell culture media is predicted to rise at a rapid pace.

An increase in research and development funding of cell culture media components, as well as a revolution in the life science sectors, particularly in biopharmaceutical products and the expansion and expansion of the biotechnology industry, all, contribute considerably to the sales of cell culture media.

In addition, the rising incidence and prevalence of cancer have shifted the attention to biosimilars, biologics, and recombinant protein products.

For more insights into the market, request a sample of thisreport@ 

Cell culture has become an essential aspect of vaccine manufacture in the pharmaceutical business. As per the latest cell culture media market future trends, vaccine demand is predicted to rise globally as the frequency of infectious diseases rises, and the possibility of pandemics rises.

Cell-based flu vaccines have also been approved for use in the United States and many European nations.

Regulatory approval of various cell culture-based vaccines around the world and increased awareness and understanding of cell culture-based vaccines are projected to propel the adoption of cell culture media forward during the forecast period.

In order to evaluate vaccines and antivirals in vitro, a culture media must be used in which the targeted virus or bacteria is cultivated, and the response is determined.

The cell culture media market opportunities and the need for culture media are fueled by the pharmaceutical industry’s increased focus on research and development. Because biopharmaceutical innovators are at the forefront of in vitro research and development for the quest for vaccines and antivirals, the present COVID-19 outbreak has a favourable impact on the cell culture media market outlook.

The global market study on cell culture media indicates that the Asia Pacific cell culture market is expected to develop due to favourable regulatory standards, government backing for cell culture-based vaccine production, cheap manufacturing costs, and global market participants’ increasing focus on the merging Asia Pacific area.

Ethical concerns over the use of animal-derived items in culture medium and a scarcity of competent professionals are expected to limit the cell culture media market share.

Cell culture media companies entail a lot of research and development for new therapeutics, including stem cells and gene therapies. Research equipment, reagents, and other goods must be of the highest quality to get reliable results.

For Information On The Research Approach Used In The Report, Ask Analyst @ 

As a result of the increased necessity to maintain high expectations (by the use of high-grade materials) and conform to strict guidelines, the price of cell biomedical research has skyrocketed. This has led cell biology research to become out of reach for many academic institutions and small businesses with minimal resources. Thus, the cell culture market opportunities and expansion are projected to be limited.

Key Takeaways

  • Serum-free media has a large market share of 51.4 per cent in 2021. Because of the low danger of contamination, serum-free media is commonly used.
  • North America has the greatest share of cell culture media applications, accounting for 32.6 per cent.
  • As per the cell culture media market analysis, cancer research accounts for 43.7 per cent of the market share for cell culture media.
  • Biopharmaceutical businesses have a market share of 83.3 per cent by end user, showing a growing need for stem cells and tissue engineering.
  • Due to increased technological advancements in the biotechnology and pharmaceutical sectors, the creation of vaccines, and expanding initiatives for in-vitro cultivations, the Asia Pacific region is expected to have a substantial potential for growth in the cell culture media market.

Competitive Landscape

As per the cell culture media market trends and forecast, because the bulk of global culture media companies is based in North America, notably in the United States, North America has the greatest market share in the global culture media market.

HiMedia Laboratories Pvt., Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Caisson Laboratories Inc., Merck & Co. Inc, Corning Incorporated, Lonza Group Ltd, Cell Culture Technologies LLC, GE Healthcare, and Fujifilm Holdings Corporation, are some of the leading cell culture media companies in the market.

For critical insights on this market, request to ask an expert here @  

As per the recent developments in cell culture media, most cultural goods were first introduced in the United States before being distributed around the world.

Due to the rising demand for cell culture mediums from various end-user industries, the top cell culture media manufacturers are focusing on increasing their research activities in plant and animal cell applications.

Key Segments

By Type:

  • Serum-free Media
  • CHO Media
  • HEK 293 Media
  • BHK Media
  • VERO Cell Media
  • Insect Cell Media
  • Serum-free Stem Cell Media
  • CAR T-cell Media

By Application:

  • Biopharmaceutical Production
  • Monoclonal antibodies
  • Vaccines production
  • Other therapeutic proteins
  • Diagnostics
  • Drug Screening & Development

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries:

Editor Details

Last Updated: 07-Jun-2022